Bhringaraja Svarasa: Benefits, Evidence & Safety

TL;DR

Bhringaraja svarasa is the fresh-pressed juice of Eclipta alba, false daisy, Ayurveda's classic hair-and-liver herb, built around the coumestan wedelolactone. Tradition uses it for hair, liver, spleen, fevers, and rheumatic pains. The modern evidence is mostly animal and lab: rat livers, rat blood sugar, rat paws. One open-label human trial of extract tablets (not the juice) cut hair shedding over 24 weeks, so treat the svarasa itself as promising but unproven.

What it is

Bhringaraja is Eclipta alba (L.) Hassk., synonym Eclipta prostrata, family Asteraceae. A small branched herb of moist, waterlogged soils. Svarasa means freshly expressed juice, usually of the leaves or the whole plant (FESympo review).

The chemistry centers on coumestans: wedelolactone and demethylwedelolactone, plus ecliptal and related flavonoids (FESympo review). One analytical study actually pressed the juice and measured it: fresh bhringaraja leaf juice came out at pH 5.9, with wedelolactone quantified by HPLC at about 0.5%, against a roughly 1.6% literature value for whole-plant material (IJBPAS 2025). Two numbers, two sources, both stated. I like this paper because it measured the actual preparation instead of theorizing about it.

Traditional use

In Ayurveda, bhringaraja is keshya (beneficial for hair) and kesharanjana (hair-darkening). The fresh juice of the leaves is rubbed on the shaven scalp to promote hair growth, and hair oils are prepared by boiling the leaves in coconut or sesame oil (IRJAY review, WisdomLib).

It is also traditionally given as a tonic and deobstruent in hepatic and splenic enlargement, and the fresh juice is advised in edema, fevers, liver disorders, and rheumatic joint pains (IRJAY review, WisdomLib). A wide brief for one juice. Traditional uses, stated as such. Not clinical proof.

What modern research says

Liver protection (animal studies)

Eclipta alba extracts showed hepatoprotective activity in rats. The specific finding I could verify: in carbon-tetrachloride-intoxicated rats, the extract reversed the loss of hepatic microsomal drug-metabolizing enzymes and restored alkaline phosphatase and lysosomal acid phosphatase toward normal, indicating protection of liver cells against chemical injury (WJRR review).

That is a real, specific, checkable result. It is also a rat result. I found no human trial of bhringaraja for liver disease, and "hepatoprotective in rats" is not a liver treatment.

Hair growth

Reviews summarize pharmacological reports of hair-growth-promoting activity for Eclipta alba, consistent with its classical keshya reputation, and attribute it to wedelolactone and related compounds (FESympo review).

The underlying work: one study applied petroleum ether and ethanol extracts in an oil-based cream to shaved rodents and measured time to hair-growth onset. Another compared petroleum ether and methanol extracts against 2% minoxidil, with the petroleum ether treatment outperforming minoxidil in that model (WJRR review). Beating minoxidil in rodents is the kind of result that gets repeated breathlessly. In rodents. The supporting studies are animal and laboratory models, not controlled human trials, so the evidence stays preliminary no matter how good the headline sounds.

Blood sugar (animal study)

Oral administration of E. alba leaf suspension at 2 and 4 g/kg for 60 days significantly reduced blood glucose and glycosylated hemoglobin in alloxan-diabetic rats. The same study found decreased glucose-6-phosphatase and fructose-1,6-bisphosphatase activity and increased liver hexokinase, the liver enzymes of glucose metabolism shifting back toward normal (JETIR review).

An animal study only. Not evidence for diabetes treatment in people. Diabetics should not touch their medication based on a rat paper.

Inflammation and antioxidant activity

In rats, E. alba produced up to 55.85% inhibition of carrageenan-induced paw edema at 3 hours, against 61.30% for indomethacin, the standard drug. Its hydroalcoholic extract scavenged DPPH, superoxide, and nitrous-oxide radicals dose-dependently in vitro (JETIR review).

Laboratory and animal evidence only. The indomethacin comparison is useful context, not a recommendation.

Safety & contraindications

One review repeats the old materia-medica note that in large doses the fresh plant acts as an emetic, causing vomiting (WJRR review). That is traditional lore rather than a toxicology finding, but the practical advice survives it: do not take the juice in excess.

There are no published human safety, pregnancy, or drug-interaction studies of bhringaraja svarasa. Pregnant and breastfeeding women should avoid it unless a qualified practitioner advises otherwise. As a member of the Asteraceae, the daisy family, it may trigger allergy in people sensitive to related plants such as ragweed or chamomile. I should be honest that this warning is general botanical caution rather than something I found in a bhringaraja-specific study. No pharmacopoeial dosage could be verified for this article, so none is stated here.

FAQs

What is bhringaraja svarasa?

The freshly expressed juice (svarasa) of the leaves or whole plant of Eclipta alba, bhringaraja or false daisy, Ayurveda's classic hair and liver herb (FESympo review). Its key active compound is wedelolactone, measured at about 0.5% in fresh leaf juice by HPLC (IJBPAS 2025).

Does bhringaraja regrow hair?

Traditional Ayurveda says yes: the fresh juice is rubbed on the scalp, and the herb is boiled into hair oils to promote growth and darken hair (IRJAY review, WisdomLib). Modern support is limited to animal and laboratory studies, including rodent work where extracts outperformed minoxidil. No controlled human trial has proven it regrows hair (FESympo review).

Is bhringaraja good for the liver?

Traditionally used for liver and spleen disorders, and animal studies show its extracts protect rat livers against chemical injury from carbon tetrachloride (WJRR review). But no human trial has tested bhringaraja for liver disease. It should not replace medical care for hepatitis or other liver conditions. I cannot say that plainly enough.

Can bhringaraja lower blood sugar?

Only in animals so far: leaf suspension reduced blood glucose in diabetic rats over 60 days (JETIR review). No human evidence. People with diabetes should not use it in place of prescribed medication or monitoring.

Are there side effects of bhringaraja juice?

In large doses it acts as an emetic, causing vomiting, per the traditional literature (WJRR review). People allergic to daisy-family plants (ragweed, chamomile, marigold) may react to it, and there is no safety data for pregnancy, breastfeeding, or drug interactions. Consult a practitioner first.

Sources

Sources, strongest first.

The pharmacological overview, covering hepatoprotective, hair-growth, antidiabetic, anti-inflammatory, and other reported activities with wedelolactone and related coumestans as the major compounds, is Munasinghe et al.'s "A Review on Pharmacological Activities of Eclipta alba (Keekirindiya-Bhringaraja)" in the Proceedings of the International Forestry and Environment Symposium (journal page). The diabetes numbers (2 and 4 g/kg, 60 days, alloxan-diabetic rats, glycosylated hemoglobin, the three liver enzymes), the 55.85% paw-edema inhibition at 3 hours, and the DPPH/superoxide/nitrous-oxide scavenging were all verified directly in Akula Mounika and Krishna Mohan's "An Extensive Review of Eclipta Alba," JETIR 10(12), 2023 (PDF).

The juice analysis, pH 5.9 and wedelolactone 0.5% by HPLC in fresh leaf juice, is Sangolli, Hiremath, and Rao's "Pharmacognostical and Analytical Study of Bhringaraja Patra Swarasa," IJBPAS 14(8), 2025 (PDF). The CCl4 hepatoprotection with lysosomal-enzyme findings, the hair-growth comparisons against minoxidil, the traditional liver/spleen/edema/fever uses, and the large-dose emetic note are from Rajesh Kumar, Sarangdevot, and Vyas's "A Review on Pharmacological Activity of Eclipta alba," World Journal of Research and Review 20(6), 2025 (PDF). The classical Ayurvedic references, samhita through nighantu, including the svarasa form for scalp indications, are from Yadav and Huddar's "A Comprehensive Review of Bhringraj (Eclipta alba L.) from Ayurveda Perspective," IRJAY 7(1):97-101, 2024 (PDF).

The one human trial — open-label, uncontrolled, 54 enrolled / 50 completed, standardized oral extract tablets for 24 weeks, comb-test shedding down 62.5% (p < 0.0001) — is Kide et al.'s "Clinical Evaluation of Standardized Bhringaraj (Eclipta alba) Extract Tablets in Hair Fall," JAIMS, 2026 (article). It tested tablets, not svarasa.

Educational only — not medical advice. Consult a qualified Ayurvedic practitioner before use.